JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
J CHILD ADOL PSYCHOP
ISSN / eISSN
1044-5463 / 1557-8992
Aims and Scope
Journal of Child and Adolescent Psychopharmacology (JCAP) is the premier peer-reviewed journal covering the clinical aspects of treating this patient population with psychotropic medications including side effects and interactions, standard doses, and research on new and existing medications. The Journal includes information on related areas of medical sciences such as advances in developmental pharmacokinetics, developmental neuroscience, metabolism, nutrition, molecular genetics, and more.
Journal of Child and Adolescent Psychopharmacology coverage includes:
New drugs and treatment strategies including the use of psycho-stimulants, selective serotonin reuptake inhibitors, mood stabilizers, and atypical antipsychotics
New developments in the diagnosis and treatment of ADHD, anxiety disorders, schizophrenia, autism spectrum disorders, bipolar disorder, eating disorders, along with other disorders
Reports of common and rare Treatment Emergent Adverse Events (TEAEs) including: hyperprolactinemia, galactorrhea, weight gain/loss, metabolic syndrome, dyslipidemia, switching phenomena, sudden death, and the potential increase of suicide. Outcomes research.
Journal of Child and Adolescent Psychopharmacology coverage includes:
New drugs and treatment strategies including the use of psycho-stimulants, selective serotonin reuptake inhibitors, mood stabilizers, and atypical antipsychotics
New developments in the diagnosis and treatment of ADHD, anxiety disorders, schizophrenia, autism spectrum disorders, bipolar disorder, eating disorders, along with other disorders
Reports of common and rare Treatment Emergent Adverse Events (TEAEs) including: hyperprolactinemia, galactorrhea, weight gain/loss, metabolic syndrome, dyslipidemia, switching phenomena, sudden death, and the potential increase of suicide. Outcomes research.
Subject Area
PEDIATRICS
PHARMACOLOGY & PHARMACY
PSYCHIATRY
CiteScore
4.40
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Medicine - Pediatrics, Perinatology and Child Health | Q1 | #69/306 |
| Medicine - Psychiatry and Mental Health | Q2 | #204/531 |
| Medicine - Pharmacology (medical) | Q2 | #108/260 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| PEDIATRICS - SCIE | Q3 |
| PHARMACOLOGY & PHARMACY - SCIE | Q4 |
| PSYCHIATRY - SCIE | Q4 |
H-index
77
Country/Area of Publication
UNITED STATES
Publisher
Mary Ann Liebert Inc.
Publication Frequency
Quarterly
Year Publication Started
1990
Annual Article Volume
50
Open Access
NO
Contact
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now